Variations in sensitivity to ionizing radiation in relation to p53 mutation point. 2008

Kumio Okaichi, and Miwa Ide-Kanematsu, and Nanaka Izumi, and Naoko Morita, and Yutaka Okumura, and Makoto Ihara
Department of Radiation Biophysics, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8523, Japan. Okaichi@net.nagasaki-u.ac.jp

Mutation of p53 is the most common genetic alteration observed in human tumours and is reported to lead to variations in cell radiosensitivity. However, the relationship between the mutation point and the degree of radiosensitivity is unclear. Saos-2 cells with different mutations of p53 were prepared and examined for radiosensitivity. Cells with p53 mutations at codons 175, 244, 245, 273 and 282 were radioresistant, whereas those with mutations at codons 123, 195, 238 and 242 were radiosensitive. Mutations at codons 130, 143, 157, 168, 277, 280 and 286 resulted in medium radiosensitivity. Thus the sensitivity of Saos-2 cells to ionizing radiation varies with the mutation point of the p53 gene.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011836 Radiation Tolerance The ability of some cells or tissues to survive lethal doses of IONIZING RADIATION. Tolerance depends on the species, cell type, and physical and chemical variables, including RADIATION-PROTECTIVE AGENTS and RADIATION-SENSITIZING AGENTS. Radiation Sensitivity,Radiosensitivity,Sensitivity, Radiation,Tolerance, Radiation,Radiation Sensitivities,Radiation Tolerances,Radiosensitivities,Sensitivities, Radiation,Tolerances, Radiation
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012516 Osteosarcoma A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed) Sarcoma, Osteogenic,Osteogenic Sarcoma,Osteosarcoma Tumor,Osteogenic Sarcomas,Osteosarcoma Tumors,Osteosarcomas,Sarcomas, Osteogenic,Tumor, Osteosarcoma,Tumors, Osteosarcoma
D014170 Transformation, Genetic Change brought about to an organisms genetic composition by unidirectional transfer (TRANSFECTION; TRANSDUCTION, GENETIC; CONJUGATION, GENETIC, etc.) and incorporation of foreign DNA into prokaryotic or eukaryotic cells by recombination of part or all of that DNA into the cell's genome. Genetic Transformation,Genetic Transformations,Transformations, Genetic
D016158 Genes, p53 Tumor suppressor genes located on the short arm of human chromosome 17 and coding for the phosphoprotein p53. Genes, TP53,TP53 Genes,p53 Genes,Gene, TP53,Gene, p53,TP53 Gene,p53 Gene
D016296 Mutagenesis Process of generating a genetic MUTATION. It may occur spontaneously or be induced by MUTAGENS. Mutageneses
D017354 Point Mutation A mutation caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair. Mutation, Point,Mutations, Point,Point Mutations
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Kumio Okaichi, and Miwa Ide-Kanematsu, and Nanaka Izumi, and Naoko Morita, and Yutaka Okumura, and Makoto Ihara
June 2011, Anticancer research,
Kumio Okaichi, and Miwa Ide-Kanematsu, and Nanaka Izumi, and Naoko Morita, and Yutaka Okumura, and Makoto Ihara
October 2004, Molecular and cellular biology,
Kumio Okaichi, and Miwa Ide-Kanematsu, and Nanaka Izumi, and Naoko Morita, and Yutaka Okumura, and Makoto Ihara
October 2001, American journal of clinical oncology,
Kumio Okaichi, and Miwa Ide-Kanematsu, and Nanaka Izumi, and Naoko Morita, and Yutaka Okumura, and Makoto Ihara
June 1998, Journal of radiation research,
Kumio Okaichi, and Miwa Ide-Kanematsu, and Nanaka Izumi, and Naoko Morita, and Yutaka Okumura, and Makoto Ihara
November 1996, Toxicology and applied pharmacology,
Kumio Okaichi, and Miwa Ide-Kanematsu, and Nanaka Izumi, and Naoko Morita, and Yutaka Okumura, and Makoto Ihara
July 2008, Cell cycle (Georgetown, Tex.),
Kumio Okaichi, and Miwa Ide-Kanematsu, and Nanaka Izumi, and Naoko Morita, and Yutaka Okumura, and Makoto Ihara
June 1993, Proceedings of the National Academy of Sciences of the United States of America,
Kumio Okaichi, and Miwa Ide-Kanematsu, and Nanaka Izumi, and Naoko Morita, and Yutaka Okumura, and Makoto Ihara
November 1963, La Presse medicale,
Kumio Okaichi, and Miwa Ide-Kanematsu, and Nanaka Izumi, and Naoko Morita, and Yutaka Okumura, and Makoto Ihara
September 2022, International journal of molecular sciences,
Kumio Okaichi, and Miwa Ide-Kanematsu, and Nanaka Izumi, and Naoko Morita, and Yutaka Okumura, and Makoto Ihara
June 1982, Applied and environmental microbiology,
Copied contents to your clipboard!